The global trypsin market consists of proteases that are found naturally occurring in the digestive system of some animals. Trypsin has advantages like good specificity and is commonly used for in vitro cell culturing and protein digestion applications in the biopharmaceutical industry. Trypsin helps in assisting the breakdown of proteins and is significantly used in various applications such as pharmaceutical production, microbiological immunoassay, genome analysis, stem cell research, and cell culture.

The Global Trypsin Market is estimated to be valued at US$ 53.83 Bn in 2024 and is expected to exhibit a CAGR of 8.6% over the forecast period 2024 To 2031.

Key Takeaways
Key players operating in the trypsin market are Pfizer, Inc., GlaxoSmithKline plc, Johnson & Johnson Services Inc., Merck & Company, Inc., Novartis AG, Amgen, Inc., AstraZeneca plc, Eli Lily and Company, AbbVie Inc., F. Hoffmann-La Roche AG, Bristol Myers Squibb Company, Biogen Inc., Sun Pharmaceutical Industries Ltd, Mylan, Inc., Aurobindo Pharma Limited, and Dr. Reddy€TMs Laboratories. The key players are focusing on strategies like partnerships, mergers & acquisitions and new product launches to expand their global footprint.

The global Trypsin Market Size is expected to witness significant growth due to rising demand from the biopharmaceutical industry. With increasing biosimilars production and new cell line development activities, the requirement for trypsin is increasing substantially. The availability of efficient recombinant and non-animal trypsin is also augmenting the market demand.

The trypsin market is anticipated to show lucrative growth opportunities across regions due to increasing investments for enhancing pharmaceutical contract manufacturing capabilities. Emerging regions like Asia-Pacific and Latin America are expected to showcase high incremental growth owing to rise of biosimilars market, increasing biopharmaceutical outsourcing activities and growing biotech research expenditure in the coming years.

Market drivers
The increasing production of monoclonal antibodies and recombinant proteins is one of the major drivers of the trypsin market. Trypsin plays an important role in cell detachment during upstream bioprocessing and is used widely for monoclonal antibody and vaccine manufacturing. Further, rising orphan drug development and cell and gene therapy research activities are also fueling the demand for trypsin globally.

The current geopolitical situation is impacting the growth of the trypsin market. Various factors like supply chain disruptions caused by the Russia-Ukraine conflict and lockdowns in China due to zero-Covid policy are hindering the market growth. Moreover, political instability and economic uncertainties in many regions are negatively affecting the research and development activities in the pharmaceutical and biotechnology industries which is a major end-use sector of trypsin. For example, declining research expenditure in the European region is impacting trypsin demand from academic institutes and research organizations.

Get more insights on Trypsin Market